MetLife Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
MetLife Stock Forecast and Price Target
The average price target for MetLife's stock set by ten recognized analysts recently is $83.00, which would result in a potential upside of approximately 15.44% if it reached this mark. The estimation is based on a high estimate of $104.00 and a low estimate of $66.00. If you're looking to buy MetLife stock, you may also want to check out its rivals.
15.44% Upside
MetLife Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, MetLife's Price has decreased from $50.39 to $0.00 – a 100.00% drop. In the next year, analysts predict that Fair Value will jump to $70.76 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BRK.A Stock Forecast | Berkshire Hathaway Inc | Outperform |
7
|
$611.56k | Buy/Sell | $621.67k | 5.47% |
| WFC Stock Forecast | Wells Fargo & | Outperform |
8
|
$59.93 | Buy/Sell | $55.70 | 5.11% |
| ELV Stock Forecast | Elevance Health | Buy |
14
|
$539.68 | Buy/Sell | $567.53 | 11.92% |
| BLK Stock Forecast | BlackRock | Outperform |
15
|
$757.65 | Buy/Sell | $883.74 | 20.44% |
| CI Stock Forecast | The Cigna Group | Outperform |
12
|
$354.51 | Buy/Sell | $354.48 | 8.60% |
MetLife Revenue Forecast for 2023 - 2025 - 2030
In the last three years, MetLife's Revenue has decreased from $67.84B to $66.90B – a 1.39% drop. In the next year, analysts predict that Revenue will jump to $72.64B – up 8.58% from the current level. Looking ahead to seven years, experts forecast that Revenue will grow by 19.24%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MMC Stock Forecast | Marsh & McLennan Companies | Hold |
9
|
$201.47 | Buy/Sell | $202.82 | 4.73% |
| CB Stock Forecast | Chubb | Outperform |
8
|
$245.96 | Buy/Sell | $243.68 | 10.59% |
| 2318 Stock Forecast | Ping An Insurance (Group) Comp... | Outperform |
10
|
HK$41.06 | Buy/Sell | HK$64.11 | 31.51% |
.jpg)
MetLife Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, MetLife's Dividend per Share has seen an increase, rising from $1.82 to $2.06. This represents a growth of 13.19%. Analysts predict that MetLife's Dividend per Share will increase in the upcoming year, reaching $2.29. This would represent an increase of 11.17%. Over the next seven years, experts predict that MetLife's Dividend per Share will grow at a rate of 27.91%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| CS Stock Forecast | AXA | Outperform |
10
|
33.80€ | Buy/Sell | 32.17€ | 9.47% |
| ZURN Stock Forecast | Zurich Insurance Group | Hold |
10
|
CHF442.60 | Buy/Sell | CHF445.39 | 4.61% |
| D05 Stock Forecast | DBS Group Holdings Ltd | Outperform |
9
|
$34.45 | Buy/Sell | $37.58 | 2.90% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 1299 Stock Forecast | AIA Group | Buy |
7
|
HK$51.55 | Buy/Sell | HK$12.90 | -76.92% |
| USB Stock Forecast | U.S. Bancorp | Outperform |
6
|
$40.99 | Buy/Sell | $48.37 | 15.88% |
| 8766 Stock Forecast | Tokio Marine Holdings | Outperform |
4
|
¥4.81k | Buy/Sell | ¥3.51k | 1.73% |
MetLife EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, MetLife has seen a decline in its EBITDA, from $8.25B to $3.92B – a 52.50% decrease. In the coming year, analysts are expecting an increase in EBITDA, predicting it will reach $8.61B – an increase of 119.61%. Over the next seven years, experts anticipate that EBITDA growth for MetLife will be 83.57%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AIG Stock Forecast | American International Group | Outperform |
8
|
$74.63 | Buy/Sell | $76.11 | 11.22% |
| TRV Stock Forecast | The Travelers Companies | Hold |
8
|
$213.99 | Buy/Sell | $215.98 | 5.38% |
| AFL Stock Forecast | Aflac | Hold |
7
|
$83.73 | Buy/Sell | $82.50 | 0.32% |
MetLife EBIT Forecast for 2023 - 2025 - 2030
In the last three years, MetLife's EBIT has decreased by 59.16%, from $7.84B to $3.20B. In the next year, analysts predict that EBIT will reach $8.26B – an increase of 158.17%. For the next seven years, the forecast is for EBIT to grow by 170.17%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALL Stock Forecast | The Allstate | Outperform |
6
|
$172.34 | Buy/Sell | $168.84 | 9.67% |
| AMP Stock Forecast | Ameriprise Financial | Outperform |
10
|
$410.91 | Buy/Sell | $420.39 | 11.95% |
| BK Stock Forecast | The Bank of New York Mellon | Outperform |
8
|
$57.18 | Buy/Sell | $60.55 | 13.68% |
MetLife EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, MetLife's EPS has decreased from $6.16 to $0.00 – a 100.00% drop. In the next year, analysts predict that EPS will jump to $8.65 – up 100.00% from the current level. Looking ahead to seven years, experts forecast that EPS will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MFC Stock Forecast | Manulife Financial | Outperform |
9
|
C$31.94 | Buy/Sell | C$29.66 | 12.71% |
| PRU Stock Forecast | Prudential Financial | Hold |
8
|
$111.18 | Buy/Sell | $107.07 | 4.34% |
| HUM Stock Forecast | Humana | Outperform |
14
|
$311.41 | Buy/Sell | $426.74 | 15.92% |
.jpg)